First Stroke Patients in Florida Treated in UM/Jackson Stem Cell Trial

The first two stroke patients have been enrolled in a phase 2 clinical trial of a revolutionary new treatment for ischemic stroke being conducted at the University of Miami/Jackson Memorial Medical Center. The trial, using a patient’s own bone marrow stem cells, is the first intra-arterial stroke stem cell trial in the U.S., and the two UM/Jackson patients are the first in Florida to participate.

Led by Dileep Yavagal, M.D., assistant professor of neurology and neurological surgery and a UM/Jackson surgeon, the trial is examining the efficacy of ALD-401, derived from bone marrow, to repair and regenerate tissue following an ischemic event.

Read more about the UM/Jackson Stem Cell Trial